Analysis of cost of medical therapy in patients of metabolic syndrome: an observational study


  • Prashant Shukla Department of Pharmacology, Government Medical College, Patiala, Punjab, India
  • Shikha Palta Department of Pharmacology, Government Medical College, Patiala, Punjab, India
  • Anita Gupta Department of Pharmacology, Government Medical College, Patiala, Punjab, India
  • Vijay K. Sehgal Department of Pharmacology, Government Medical College, Patiala, Punjab, India



Cost of Medical therapy, Diabetes mellitus, Hypertension, Metabolic syndrome, Pharmacoeconomics


Background: The objective of the study was to analyze cost of medical therapy in patients of Metabolic syndrome.

Methods: This was an observational study. The study was conducted by enrolling patients of the outpatient department of Medicine of Rajindra Hospital, Government Medical College, Patiala, Punjab. A total of 100 patients diagnosed with Metabolic syndrome were enrolled in the study. The total daily cost of the therapy was calculated by adding the direct cost of individual drugs taking in consideration the frequency of the drug. The daily cost of therapy was then extrapolated to calculate the monthly as well as annual cost of therapy.

Results: The mean age of patients was 58.27±10.32 years. Out of a total of 100 patients, there were 57 female and 43 male patients, indicating a female preponderance of the disease. The average individual daily cost of medical therapy is INR 44.56 which upon extrapolation gives monthly and annual cost of INR 1336.90 and INR 16264.40 respectively. The cost of treatment in males is costlier than females (INR 50.09 in males versus INR 40.22 in females). The cost of treatment of age 31-40 years is INR 27.90 while it INR 36.97, 48.16 and 50.75 for age groups 41-50, 51-60 and 61-70 years. The various components of metabolic syndrome viz. diabetes mellitus, hypertension and dyslipidemia contribute differently to the cost of therapy. Daily cost of medical therapy for diabetes mellitus is INR 18.57 while for hypertension and dyslipidemia are INR 10.25 and INR 6.13 respectively.

Conclusions: Chronic diseases like metabolic syndrome have a huge share of the healthcare budget. Given the fact that it is a lifestyle disease, its prevalence is likely to swell in the coming decades. Hence, formulation of preventive and innovative treatment guidelines is of utmost importance.


Milici N. A short history of the metabolic syndrome definitions. Proc Rom Acad, Series B. 2010;1:13-20.

Boudreau DM, Malone DC, Raebel MA, Fishman PA, Nicholas GA, Feldstein AC et al. Health care utilization and costs by metabolic syndrome risk factors. Metab Syndr Relat Disord. 2009;7(4):305-14.

Tziallas D, Kastanioti C, Savvas K, Kostapanos MS, Tziallas V, Skapinakis P, et al. Evaluation of Health Related Quality of Life in Patients with Metabolic Syndrome. Health Science J. 2012;6(1):116-28.

Sawant A, Mankeshwar R, Shah S, Raghvan R, Dhongde G, Raje H et al. Prevalence of Metabolic syndrome in Urban India. Cholesterol. 2011:1-7.

Mangat C, Goel NK, Walia DK, Agarwal N, Sharma MK, Kaur J et al. Metabolic syndrome: a challenging health issue in highly urbanized union territory of north India. Diabetol Metab Syndr. 2010;2:19.

Sinha S, Misra P, Kant S, Krishnan A, Nongkynrih B, Vikram NK. Prevalence of metabolic syndrome and its selected determinants among urban adult women in South Delhi, India. Postgrad Med J. 2013;89:68-72.

Patel NR, Patel HL, Gunjalia AP. Prevalence of metabolic syndrome in higher socioeconomic class of Ahmedabad, Gujarat, India. Int J Med Sci Public Health. 2016;5(1): 35-9.

Chakraborty SN, Roy SK, Rahaman MA. Epidemiological predictors of metabolic syndrome in urban West Bengal, India. J Family Med Prim Care. 2015;4(4):535-8.

Pradeepa R, Surendar J, Indulekha K, Chella S, Anjana RM, Mohan V. Prevalence of metabolic syndrome and its association with coronary artery disease among an urban elderly south Indian population (CURES 145). J Assoc Physicians India. 2016;64:20-5.

Madan JG, Narsaria AM. Prevalence of metabolic syndrome in Mumbai City, india. Jobe Metab Res. 2016;3:16-22.

Bhattacharyya A, Sinha N. Attributes of metabolic syndrome in geriatric institutional residents in Secunderabad, India. Int J Res Med Sci 2016;4:398-402.

Sinha N, Bhattacharya A, Deshmukh PR, Panja TK, Yasmin S, Arlappa N. Metabolic syndrome among eldery care- home residents in southern India: a cross-sectional study. WHO South-East Asia J Public Health. 2016;5(1):62-9.

Health Economics Information Resources: A Self-Study Course. National Information Center on Health Services Research and Health Care Technology (NICHSR). U.S. National Library of Medicine. [Last updated: 12 July 2016; cited: 25 Oct 2016] Available at: nichsr/edu/healthecon/glossary.html

Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006;23(5):469-80.

Current Index of Medical Specialties and Monthly Index of Medical Specialties. 2015. [updated 2016; cited 2015 Oct 25]. Available from:

Preventing Chronic diseases a vital investment. World Health Organization. Public health agency of Canada.pp.35. [updated 2016; cited 2017 Feb 25]. Available from:

Glossary of Frequently Encountered Terms in Health Economics. Health Economics Information Resources: A Self-Study Course. National Library of Medicine. [updated 2016; cited 2017 Feb 25]. Available from:

Shah SN. The Metabolic Syndrome - Health and Economic Impact: The Indian Scene [Internet]. Post graduate Medicine; 2008 [cited: 2015 Sep 28]. Available from Netlibrary: Chapter-25.pdf

Kumar A, Nagpal J, Bhartia A. Direct cost of ambulatory care of type 2 diabetes in the middle and high income group populace of Delhi: the DEDICOM survey.J Assoc Physicians India. 2008; 56():667-74.

Curtis LH, Hammill BG, Bethel MA, Anstrom KJ, Gottdiener JS, Schulman KA. Costs of the Metabolic Syndrome in Elderly Individuals. Diabetes Care. 2007;30(10):2553-8.

Nicholas GA, Moler EJ. Metabolic Syndrome Components Are Associated with Future Medical Costs Independent of Cardiovascular Hospitalization and Incident Diabetes. Met syn Rel disorders. 2011;9(2):127-33.

Bovet P, Shamlaye C, Gabriel A, Riesen W, Paccaud F. Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy. BMC Public Health 2006, 6:9

Census of India: Age Structure and Marital Status. Available from:

Economic survey 2014-15. Statistical appendix. Available at:




How to Cite

Shukla, P., Palta, S., Gupta, A., & Sehgal, V. K. (2018). Analysis of cost of medical therapy in patients of metabolic syndrome: an observational study. International Journal of Research in Medical Sciences, 6(2), 443–447.



Original Research Articles